Immunological Data Discovery Index
Advanced Search
identifier: 2114167
description:
epitope description:P75, E76, H79, Q107, P108, M110, K111, L112, G113, T114, Q115, T116, V117, P118, C119, T148, L150, R194, R195, F196, E198, A199, C201, E233, K234
antigen name:ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
host organism:Mus musculus
antibody name:SAR650984
aggregation:
instance of dataset
availability:
available
primaryPublications: 24987056
authorizations:
registration not required
accessURL: http://www.iedb.org/reference/1027976
landingPage: http://www.iedb.org/assay/2114167
type:
Literature
publicationVenue:
Clin Cancer Res
dates:
2014
study type: b cell assays
subject species: Homo sapiens
fullName:
Jutta Deckert
Marie-Cé
cile Wetzel
Laura M Bartle
Anna Skaletskaya
Victor S Goldmacher
Franç
ois Vallé
e
Qing Zhou-Liu
Paul Ferrari
Sté
phanie Pouzieux
Charlotte Lahoute
Charles Dumontet
Adriana Plesa
Marielle Chiron
Pascale Lejeune
Thomas Chittenden
Peter U Park
ronique Blanc
method:
biological activity
name:
SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies.
description:
The epitope residues were calculated from [PDB: 4CMH] as the antigen residues at 4Å
atomic distance from the antibody.
The epitope-specific SAR650984 antibody bound to CD38 on Raji, Daudi or Ramos lymphoma cells and other cell lines and displayed pro-apoptotic activity in the absence of cross-linking agents, as determined by Annexin V-positive staining and cell lysis. SAR650984 also induced apoptosis without added cross-linking agents in primary cells isolated from bone marrow of multiple myeloma patients.

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on Feedback.